Share on Pinterest Is FluMist, the at-home nasal vaccine that was recently approved by the FDA, as effective at preventing ...

At-home healthcare is seeing a boom across the country. Most recently, the FDA approved the nasal flu vaccine for at-home ...

According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, ...

The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the ...

FluMist Home, like the original version administered in medical offices and pharmacies, is for adults under age 50 and kids 2 ...

FluMist contains a weakened form of live flu virus strains and is sprayed into the nose. “The nasal spray is a live vaccine ...

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...

The FluMist vaccine can now be self-administered after the FDA approved its use to treat the influenza disease.

Since its initial US approval in 2003, 200 million doses of FluMist have been distributed globally. The new ...

First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider ...